Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Team GB athlete Lina Nielsen is starting treatment for multiple sclerosis – a decade after being diagnosed. She tells The i ...

Selma Blair opens up to PEOPLE about still keeping a “beginner’s mind” in her multiple sclerosis journey, and why she’s ...

Scientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.

Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform. In return, ...

Researchers at Linköping University in Sweden made an unexpected discovery while investigating genetically unique women.

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Nicole Pedra, who was diagnosed with Multiple Sclerosis when she was 10, recently took to TikTok to share some 'invisible' ...

Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...

Eye-disease-focused Acelyrin will be absorbed into immune-mediated disease specialist Alumis as part of an all-stock merger.